Stock CRSP CRISPR THERAPEUTICS AG
Add to a list
To use this feature you must be a member
Log inSign up

Revisions CRISPR Therapeutics AG

Equities

CRSP

CH0334081137

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
56.16 USD +1.08% Intraday chart for CRISPR Therapeutics AG -10.73% -10.29%
Apr. 18 Citigroup Adjusts CRISPR Therapeutics' Price Target to $89 From $88, Keeps Buy Rating MT
Apr. 17 Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. CRSP Stock
  4. Revisions CRISPR Therapeutics AG